Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (2S, 3R) BHBM. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115433721B details a carbonyl reductase mutant for BHBM synthesis, offering water-based media and superior thermal stability for cost-effective pharma manufacturing.